Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of $40.00.

CIBC's Dodig will remain on the board as a special adviser to incoming CEO Harry Culham and the board until April 30, 2026. Culiham is to take the CEO position on Nov. 1. The lender reaffirmed its ...

Stock analysts at Stifel Nicolaus initiated coverage on shares of Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) in a research ...

Bank of New York Mellon Corp increased its position in shares of Stantec Inc. (NYSE:STN – Free Report) (TSE:STN) by 5.9% in ...

A Finra panel ruled the firm's conduct overconcentrated the family in structured notes and limited industries.

Investors are selling shares of financial companies as they weigh the impacts of tariffs and slower economic growth.

The largest arbitration award granted to retail clients is the third ruling against Stifel involving advisor Chuck Roberts. More cases are in the pipeline.

Shares of Intel are skyrocketing on Thursday, primarily because the company announced that Lip-Bu Tan will be its new CEO ...

The U.S. Treasury on Thursday confirmed that a license allowing a wind-down of energy transactions with Russian financial institutions expired as scheduled this week under stiff sanctions imposed in ...

BERLIN — Germany's likely next government under conservative leader Friedrich Merz has said it plans a shot in the arm for ...

Following these changes, the Company's Board of Directors and executive officers consist of: Timothy Chan (Chief Executive Officer and Director), Peter Rhodes (Chief Financial Officer), Jon Bey ...

Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Nike by 3.4% in Q4, acquiring 18,407 additional shares. This ...